Trial Profile
A Large, Single-Arm, Multicentre Clinical Study Investigating the Safety and Efficacy of Collagenase Clostridium Histolyticum (CCH- Xiapex) and Building a Novel Nomogram for Predicting the Probability of Penile Curvature Improvement in Patients with Peyronie's disease (PD) using a New Shortened Protocol
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Jul 2018
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Peyronie's disease
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2018 New trial record